- Home
- SLQT vs EDIT Comparison
SLQT vs EDIT Comparison
Compare SLQT & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- EDIT
- Stock Information
- Founded
- SLQT 1999
- EDIT 2013
- Country
- SLQT United States
- EDIT United States
- Employees
- SLQT N/A
- EDIT N/A
- Industry
- SLQT Specialty Insurers
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SLQT Finance
- EDIT Health Care
- Exchange
- SLQT Nasdaq
- EDIT Nasdaq
- Market Cap
- SLQT 281.6M
- EDIT 269.8M
- IPO Year
- SLQT 2020
- EDIT 2016
- Fundamental
- Price
- SLQT $1.43
- EDIT $2.45
- Analyst Decision
- SLQT Hold
- EDIT Buy
- Analyst Count
- SLQT 2
- EDIT 10
- Target Price
- SLQT $3.88
- EDIT $4.13
- AVG Volume (30 Days)
- SLQT 1.2M
- EDIT 2.3M
- Earning Date
- SLQT 11-06-2025
- EDIT 11-10-2025
- Dividend Yield
- SLQT N/A
- EDIT N/A
- EPS Growth
- SLQT N/A
- EDIT N/A
- EPS
- SLQT N/A
- EDIT N/A
- Revenue
- SLQT $1,563,142,000.00
- EDIT $46,383,000.00
- Revenue This Year
- SLQT $13.98
- EDIT N/A
- Revenue Next Year
- SLQT $9.54
- EDIT N/A
- P/E Ratio
- SLQT $11.55
- EDIT N/A
- Revenue Growth
- SLQT 13.16
- EDIT N/A
- 52 Week Low
- SLQT $1.33
- EDIT $0.91
- 52 Week High
- SLQT $6.86
- EDIT $4.54
- Technical
- Relative Strength Index (RSI)
- SLQT 32.52
- EDIT 34.53
- Support Level
- SLQT $1.33
- EDIT $2.45
- Resistance Level
- SLQT $1.48
- EDIT $2.73
- Average True Range (ATR)
- SLQT 0.12
- EDIT 0.20
- MACD
- SLQT -0.04
- EDIT -0.01
- Stochastic Oscillator
- SLQT 11.98
- EDIT 21.32
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.